<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">Strains of the classical biotype of 
 <italic>V</italic>. 
 <italic>cholerae</italic> O1 have been found to carry a CRISPR-Cas system
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>,
  <xref ref-type="bibr" rid="CR19">19</xref>,
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup>, which belongs to the previously described type I-E subtype
 <sup>
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup>. However, all available genomic sequence data reveal the absence of CRISPR-Cas system in El Tor biotype strains
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. On the other hand PLEs that respond to infection by ICP1 phages are widespread among 
 <italic>V</italic>. 
 <italic>cholerae</italic>, and consequently PLE mediated inhibition of phage replication is likely to be prominent in 
 <italic>V</italic>. 
 <italic>cholerae</italic> O1 of the El Tor biotype
 <sup>
  <xref ref-type="bibr" rid="CR18">18</xref>
 </sup>. Although CRISPR-Cas systems are usually carried by bacteria or archea, recently 
 <italic>V</italic>. 
 <italic>cholerae</italic> specific ICP1 phages have been shown to carry a CRISPR-Cas system
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. Most of the spacer sequences of the CRISPR arrays carried by these phages show 100% sequence identity with different regions of the 18-kb PLE carried by some 
 <italic>V</italic>. 
 <italic>cholerae</italic> O1 El Tor biotype strains
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. Consequently, the phage encoded CRISPR-Cas system can inactivate the function of PLEs in interfering with phage-reproduction in these strains. The occurrence of a CRISPR-Cas system in cholera phages represents a remarkable event in microbial arms-race and thus warrants further studies to better understand the distribution and evolution of the phage encoded CRISPR-Cas system, and co-evolution of 
 <italic>V</italic>. 
 <italic>cholerae</italic>. Besides, this knowledge would have significance in developing potential phage mediated interventions to control cholera or other bacterial infections.
</p>
